InsiderTrades

Form 4 for CYRX Cryoport, Inc.

Accepted 2025-06-26 00:00:00 ET · period of report 2025-06-24 · accession 0001104659-25-063166 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-06-26 2025-06-24+ CYRX SHELTON JERRELL Pres, CEO, Dir M - OptEx $5.00 +41.3K 928.8K +5% +$206.7K
D 2025-06-26 2025-06-24 CYRX SHELTON JERRELL Pres, CEO, Dir S - Sale+OE $7.06 -16.3K 912.4K -2% -$115.4K
DM 2025-06-26 2025-06-24+ CYRX SHELTON JERRELL Pres, CEO, Dir M - OptEx $0.00 -41.3K 125.0K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-25 M A 25,000 $5.00 937,419 D — — (F3) This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
2 Common Common Stock 2025-06-24 M A 16,344 $5.00 928,763 D — — (F1) This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025.
3 Common Common Stock 2025-06-24 S D 16,344 $7.06 912,419 D — — (F1) This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $7.31, inclusive.
4 Derivative Stock Option (right to buy) 2025-06-24 M D 16,344 $0.00 150,000 D $5.00 · — to 2025-08-20 16,344 Common Stock (F1) This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. (F4) 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.
5 Derivative Stock Option (right to buy) 2025-06-25 M D 25,000 $0.00 125,000 D $5.00 · — to 2025-08-20 25,000 Common Stock (F3) This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. (F4) 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.